DSIP
(Delta Sleep-Inducing Peptide)
Restorative Sleep & Recovery Support
WHAT IT IS:
A naturally occurring neuropeptide that helps regulate the body's sleep architecture, support deep restorative sleep, and modulate the stress response.
WHY YOU NEED IT:
Clinically Studied Mechanism for Sleep Regulation
Important for patients with chronic insomnia, fragmented sleep, or difficulty reaching deep (slow-wave) sleep
Targets patients who do not want sedative-hypnotic medications (such as zolpidem, eszopiclone, or benzodiazepines) or have failed them
Supports patients who fall asleep but wake repeatedly through the night and feel unrefreshed in the morning
Good for patients whose sleep has been disrupted by stress, shift work, travel, or hormonal changes (perimenopause, andropause)
Great for high-performing executives, professionals, and athletes who need consistent recovery and cognitive sharpness
Supports patients with elevated stress, dysregulated cortisol rhythms, or signs of HPA-axis dysfunction
Targets athletes and active individuals seeking enhanced muscle recovery, growth hormone support, and reduced perception of fatigue
Important for patients seeking a non-habit-forming sleep protocol that does not impair next-day cognition
HOW IT HELPS:
Restorative sleep is rarely just about how many hours you spend in bed — it's about the quality and architecture of the sleep itself. The brain cycles through distinct stages each night, and the deepest of these — slow-wave (delta) sleep — is when the body repairs tissue, consolidates memory, regulates hormones, and clears metabolic waste from the brain.
DSIP (Delta Sleep-Inducing Peptide) is designed to support the brain's natural sleep-regulating systems, as well as the depth and rhythm of healthy sleep.
DSIP is a small, naturally occurring neuropeptide first isolated in the 1970s. It appears to play a modulatory role in the sleep-wake cycle, stress response, and circadian rhythm. Unlike sedative-hypnotic drugs that force sleep through GABAergic suppression of the central nervous system, DSIP appears to support the brain's own sleep-promoting pathways.
A Different Pathway from Conventional Sleep Aids
Most prescription and over-the-counter sleep aids work by sedating the brain. While they can shorten the time to fall asleep, they often suppress slow-wave and REM sleep (not good!), leave patients groggy the next morning, and carry risk of tolerance, dependence, and dementia with long-term use.
DSIP works through a fundamentally different mechanism. Rather than sedating the brain, it appears to modulate the neuroendocrine systems that govern sleep onset, sleep depth, and stress regulation — supporting the body's own ability to enter and sustain restorative sleep.
Enhanced Sleep Depth and Continuity
Clinical and preclinical research suggests DSIP may help increase time spent in slow-wave (delta) sleep, reduce nighttime awakenings, and improve overall sleep continuity. Many patients report falling asleep more easily, sleeping through the night with fewer interruptions, and waking with a greater sense of refreshment and mental clarity. For patients who have spent years feeling that real, restorative sleep was always just out of reach, this shift can be profound.
Stress and Cortisol Modulation
DSIP has been studied for its effects on the hypothalamic-pituitary-adrenal (HPA) axis — the central stress-response system. Evidence suggests it may help moderate elevated cortisol, support a healthier circadian cortisol rhythm, and reduce the physiological signature of chronic stress. This makes DSIP particularly relevant for patients whose poor sleep is driven by stress, anxiety, or burnout.
Recovery and Athletic Performance
Because the deepest stages of sleep are when the body releases growth hormone, repairs muscle tissue, and consolidates motor learning, improving sleep quality has direct downstream benefits for physical recovery. DSIP has been studied in athletic populations for its potential to reduce perception of fatigue, support recovery between training sessions, and enhance the body's natural growth hormone pulse during deep sleep. For athletes, active patients, and anyone with high physical demands, better sleep means better recovery.
Clinical Evidence
DSIP has been studied for over four decades in both human and animal research. Early clinical work in the 1980s demonstrated improvements in sleep onset, sleep efficiency, and subjective sleep quality in patients with chronic insomnia. Subsequent research has explored its role in stress modulation, withdrawal syndromes, and pain perception. While DSIP remains an investigational compound and is not FDA-approved as a pharmaceutical, the body of peer-reviewed literature supports its use as a well-tolerated peptide that influences sleep and stress physiology through endogenous pathways.
What to Expect
DSIP is administered as a subcutaneous injection, typically in the evening, about 30 to 60 minutes before bed. Most patients begin to notice changes in sleep quality within the first one to two weeks, with continued improvement over four to eight weeks of consistent use. Side effects are uncommon and generally mild — most often transient injection site reactions, mild headache, or vivid dreams as sleep architecture shifts. DSIP is non-sedating and non-habit-forming; it generally does not impair next-day alertness, motor coordination, or cognition.
Who Should Not Use DSIP
DSIP is not appropriate for women who are pregnant or breastfeeding, patients with known hypersensitivity to peptide therapies, patients with active malignancy unless cleared by their oncologist, or those with unstable endocrine or psychiatric conditions without physician supervision. Some patients taking sedative-hypnotic medications, benzodiazepines, or other central nervous system depressants may not be candidates for DSIP.
DOSAGE:
Starting Dose: 100 mcg by subcutaneous injection, taken 30–60 minutes before bedtime.
Titration: Dose may be adjusted under physician supervision, with typical maintenance ranging from 100 mcg to 250 mcg nightly, based on response and tolerance. Use cyclical dosing (e.g., 5 nights on, 2 nights off) to maintain responsiveness.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.